Adenovirus Clinical Trial
Official title:
An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
| NCT number | NCT02596997 |
| Other study ID # | CMX001-351 |
| Secondary ID | |
| Status | No longer available |
| Phase | |
| First received | |
| Last updated |
| Verified date | February 2020 |
| Source | Chimerix |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Expanded Access |
Provide patients with serious AdV infection or disease access to treatment with BCV.
| Status | No longer available |
| Enrollment | 0 |
| Est. completion date | |
| Est. primary completion date | |
| Accepts healthy volunteers | |
| Gender | All |
| Age group | 2 Months and older |
| Eligibility | Inclusion Criteria: - Confirmed serious AdV infection based on clinical symptoms and laboratory testing showing AdV in the blood or other bodily fluids - Able to swallow medication, either tablet or liquid Exclusion Criteria: - Previous dosing with Brincidofovir - If female, not pregnant or trying to become pregnant |
| Country | Name | City | State |
|---|---|---|---|
| United States | Emory University-AFLAC Cancer and Blood Disorder Clinic | Atlanta | Georgia |
| United States | Children's Hospital Colorado | Aurora | Colorado |
| United States | Brigham & Woman's Hospital/Boston | Boston | Massachusetts |
| United States | The Children's Hospital at Montefiore | Bronx | New York |
| United States | Levine Children's Hospital | Charlotte | North Carolina |
| United States | Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago | Illinois |
| United States | University of Chicago | Chicago | Illinois |
| United States | Cincinnatti Children's Hospital | Cincinnati | Ohio |
| United States | Cleveland Clinic | Cleveland | Ohio |
| United States | Nationwide Children's Hospital | Columbus | Ohio |
| United States | UT Southwestern Medical Center | Dallas | Texas |
| United States | Duke University Medical System | Durham | North Carolina |
| United States | Cook Children's Health Care System | Fort Worth | Texas |
| United States | University of Florida | Gainesville | Florida |
| United States | Michigan State/Spectrum Health | Grand Rapids | Michigan |
| United States | Hackensack University MC | Hackensack | New Jersey |
| United States | Baylor College of Medicine-Infectious Disease | Houston | Texas |
| United States | University of Texas, MD Anderson Cancer Center | Houston | Texas |
| United States | Children's Mercy Hospital | Kansas City | Kansas |
| United States | University of Arkansas Medical Center | Little Rock | Arkansas |
| United States | Children's Hospital LA | Los Angeles | California |
| United States | UCLA Medical Center | Los Angeles | California |
| United States | University of Louisville-Kosair Childrens Hospital | Louisville | Kentucky |
| United States | Methodist University Hospital-BMT program west clinic | Memphis | Tennessee |
| United States | St. Jude Research Hospital | Memphis | Tennessee |
| United States | Children's Hospital New Orleans | New Orleans | Louisiana |
| United States | Memorial Sloan Kettering | New York | New York |
| United States | Morgan Stanley Children's Hospital | New York | New York |
| United States | New York Medical College-Maria Fareri Childrens hospital | New York | New York |
| United States | Weill Conrell Medical Center | New York | New York |
| United States | University of Nebraska | Omaha | Nebraska |
| United States | Children's Hospital of Orange County | Orange | California |
| United States | Pediatric Stem Cell Transplantation Stanford University | Palo Alto | California |
| United States | Stanford University | Palo Alto | California |
| United States | The Childrens hospital of Philadelphia | Philadelphia | Pennsylvania |
| United States | Washington University | Saint Louis | Missouri |
| United States | All Children's Research Institute | Saint Petersburg | Florida |
| United States | All Childrens Research Institute | Saint Petersburg | Florida |
| United States | Methodist Children's Hospital of South Texas | San Antonio | Texas |
| United States | UC San Diego Moores Cancer center | San Diego | California |
| United States | University of California San Francisco Benioff Children's Hospital | San Francisco | California |
| United States | Fred Hutchinson Cancer Research Center | Seattle | Washington |
| United States | University of Washington/ Seattle Children's Hospital | Seattle | Washington |
| United States | New York Medical College, Maria Fareri Children's Hospital | Valhalla | New York |
| United States | Children's National Medical Center | Washington | District of Columbia |
| United States | Medical College of Wisconsin | Wauwatosa | Wisconsin |
| Lead Sponsor | Collaborator |
|---|---|
| Chimerix |
United States,
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02984280 -
Specific Respiratory Infections as Triggers of Acute Medical Events
|
N/A | |
| Recruiting |
NCT03665675 -
Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
|
Early Phase 1 | |
| Completed |
NCT01431326 -
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
|
||
| Recruiting |
NCT03266627 -
Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
|
Phase 2 | |
| Not yet recruiting |
NCT03325517 -
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics
|
N/A | |
| Not yet recruiting |
NCT06392451 -
LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia
|
N/A | |
| Recruiting |
NCT05183490 -
R-MVST Cells for Treatment of Viral Infections
|
Phase 1 | |
| Completed |
NCT04056546 -
Interest of Rapid Typing in Adenovirus Infections.
|
||
| Withdrawn |
NCT00448994 -
Adenovirus and Fungal Load in Pediatric Stem Cell Transplant Patients
|
N/A | |
| Recruiting |
NCT06299813 -
Effectiveness of a Single Dose of Betamethasone in Children With Symptomatic Adenovirus Infection
|
Phase 3 | |
| Enrolling by invitation |
NCT06027879 -
Anti-viral T-cell Therapy by Gamma Capture
|
Phase 1/Phase 2 | |
| Recruiting |
NCT02779439 -
Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation
|
Phase 1 | |
| Terminated |
NCT02420080 -
A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304
|
N/A | |
| Active, not recruiting |
NCT01945814 -
Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL)
|
Phase 1 | |
| Completed |
NCT01535885 -
Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV
|
Phase 1 | |
| Terminated |
NCT03339401 -
The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation
|
Phase 2 | |
| Withdrawn |
NCT01584037 -
Adenovirus Vaccine Pregnancy Registry
|
N/A | |
| Withdrawn |
NCT03532035 -
Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia
|
Phase 2 | |
| Recruiting |
NCT02008812 -
Ad Sensor-based Real-time Diagnosis of Adenovirus
|
N/A | |
| Active, not recruiting |
NCT04364178 -
Viral Specific T-Lymphocytes to Treat Adenovirus or CMV
|
Phase 1/Phase 2 |